Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 1
2020 2
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
COPD phenotypes: differences in survival.
Hernández Vázquez J, Ali García I, Jiménez-García R, Álvaro Meca A, López de Andrés A, Matesanz Ruiz C, Buendía García MJ, de Miguel Díez J. Hernández Vázquez J, et al. Among authors: ali garcia i. Int J Chron Obstruct Pulmon Dis. 2018 Jul 20;13:2245-2251. doi: 10.2147/COPD.S166163. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30050297 Free PMC article.
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT; TACKLE study group. Montgomery H, et al. Lancet Respir Med. 2022 Oct;10(10):985-996. doi: 10.1016/S2213-2600(22)00180-1. Epub 2022 Jun 7. Lancet Respir Med. 2022. PMID: 35688164 Free PMC article. Clinical Trial.
Influence of Comorbidities on the Survival of COPD Patients According to Phenotypes.
Ji Z, Hernández-Vázquez J, Domínguez-Zabaleta IM, Xia Z, Bellón-Cano JM, Gallo-González V, Ali-García I, Matesanz-Ruiz C, López-de-Andrés A, Jiménez-García R, Buendía-García MJ, Gómez-Sacristán Á, Girón-Matute WI, Puente-Maestu L, de Miguel-Díez J. Ji Z, et al. Among authors: ali garcia i. Int J Chron Obstruct Pulmon Dis. 2020 Oct 30;15:2759-2767. doi: 10.2147/COPD.S270770. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33154636 Free PMC article.
Differences in Survival of Patients With COPD According to the New GesEPOC 2021 Classification of Phenotypes.
Ji Z, Hernández-Vázquez J, Esteban-Yagüe M, García-Valentín P, Bellón-Cano JM, Domínguez-Zabaleta IM, Ali-García I, Matesanz-Ruiz C, Buendía-García MJ, de Miguel-Díez J. Ji Z, et al. Among authors: ali garcia i. Open Respir Arch. 2022 Oct 3;4(4):100212. doi: 10.1016/j.opresp.2022.100212. eCollection 2022 Oct-Dec. Open Respir Arch. 2022. PMID: 37496957 Free PMC article.
Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients.
Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, Gutiérrez-Pereyra F, Tarragona E, Palomino R, López-Viña A; TAI Study Group. Plaza V, et al. J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):142-52. doi: 10.1089/jamp.2015.1212. Epub 2015 Jul 31. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26230150 Free PMC article.